EPISODE скачать в хорошем качестве

EPISODE

On the latest episode of The Cannabis Conversation, we speak with Dr. Franjo Grotenhermen, Chairperson at the International Association of Cannabinoid Medicines (IACM). We explore his journey into cannabis medicine, its diverse uses, and the challenges of its regulation. Together, we look at the importance of patient experiences and the need for a balance between clinical trials and real-world experiences. We also examine the risk profile of cannabis, potential side effects, contraindications, and interactions with other medications.  The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at https://www.luminorecruit.com About Franjo Grotenhermen M.D. Franjo Grotenhermen graduated in medicine and received his doctorate in Cologne. His fields of practice included internal medicine, surgery and naturopathy. He is head of the Centre for Cannabis Medicine in Steinheim (NRW) with a focus on therapy with cannabis and cannabinoids. Grotenhermen is Executive Director of the Arbeitsgemeinschaft Cannabis als Medizin e.V. (ACM) (since 1997), Executive Director of the International Alliance for Cannabinoid Medicines (IACM) (since 2000) and author of the IACM-Bulletin, which is published fortnightly in several languages on the IACM website. Grotenhermen is an employee of the Cologne-based nova Institute, co-owner of Endoxo GmbH (founded in 2019), a company that produces CBD and other hemp products. He is a lecturer at Dresden International University. He is Chief Medical Advisor of canncura, an internet platform for telemedicine in the field of cannabis and cannabinoids. He is a member of the Scientific Advisory Board of the journals Cannabis and Cannabinoid Research, edited by Prof. Daniele Piomelli at Mary Ann Liebert Publishing. He received the following awards: Hanf-Preis 1999 of Cannabusiness, IACM 2011 Special Award, ICBC 2018 Lifetime Achievement Award, Robert Newman Memorial Award 2018 of Akzept e.V., Honorary Award GFS-Award 2021 of Gemeinnützige Forschungsvereinigung Saluplanta e.V. Connect with Franjo on LinkedIn:   / franjo-grotenhermen-65624b19b   International Association of Cannabinoid Medicines (IACM)’s Website: https://cannabis-med.org/